Complications | ENPG (N = 10) | IMRT (N = 220) | P* | ||
---|---|---|---|---|---|
n | % | n | % | ||
Auditory/hearing | 0.069 | ||||
 0 | 10 | 100 | 138 | 62.7 |  |
 1–2 | 0 | 0 | 63 | 28.7 |  |
 3–4 | 0 | 0 | 19 | 8.6 |  |
Trismus | 0.369 | ||||
 0 | 10 | 100 | 184 | 83.6 |  |
 1–2 | 0 | 0 | 36 | 16.4 |  |
 3–4 | 0 | 0 | 0 | 0 |  |
Dysphagia | 0.674 | ||||
 0 | 10 | 100 | 190 | 86.4 |  |
 1–2 | 0 | 0 | 26 | 11.8 |  |
 3–4 | 0 | 0 | 4 | 1.8 |  |
Skin | Â | Â | Â | Â | 1.000 |
 0 | 9 | 90.0 | 193 | 87.7 |  |
 1–2 | 1 | 10.0 | 25 | 11.4 |  |
 3–4 | 0 | 0 | 2 | 0.9 |  |
Subcutaneous soft tissue | 0.611 | ||||
 0 | 10 | 100 | 193 | 87.7 |  |
 1–2 | 0 | 0 | 27 | 12.3 |  |
 3–4 | 0 | 0 | 0 | 0 |  |
Dry mouth | < 0.001 | ||||
 0 | 9 | 90.0 | 52 | 23.6 |  |
 1–2 | 1 | 10.0 | 119 | 54.1 |  |
 3–4 | 0 | 0 | 49 | 22.3 |  |
Cranial neuropathy | 0.473 | ||||
 0 | 10 | 100 | 207 | 94.1 |  |
 1–2 | 0 | 0 | 13 | 5.9 |  |
 3–4 | 0 | 0 | 0 | 0 |  |
Peripheral neuropathy | 1.000 | ||||
 0 | 10 | 100 | 218 | 99.1 |  |
 1–2 | 0 | 0 | 2 | 0.9 |  |
 3–4 | 0 | 0 | 0 | 0 |  |
Endocrine dysfunction | 1.000 | ||||
 0 | 10 | 100 | 211 | 95.9 |  |
 1–2 | 0 | 0 | 9 | 4.1 |  |
 3–4 | 0 | 0 | 0 | 0 |  |
Temporal lobe necrosis | 1.000 | ||||
 0 | 10 | 100 | 205 | 93.2 |  |
 1–2 | 0 | 0 | 15 | 6.8 |  |
 3–4 | 0 | 0 | 0 | 0 |  |